HelpAcademyLoginJoin us as a Member

Petros Pharmaceuticals, Inc.

Sign in to save Petros Pharmaceuticals, Inc. to a watchlist Sign in to set an alert for Petros Pharmaceuticals, Inc.
Tickers
PTPI
Headquarters
Not recorded
SEC CIK
0001815903
Website
Not recorded

Closing prices

Drugs

No drugs from this company are tracked yet.

FDA-approved applications

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

SEC filings

SEC filings from Petros Pharmaceuticals, Inc., newest first
FormFiledWhat it coversDocument
8-K Current report (8-K)
  • Bankruptcy or receivership (Item 1.03)
  • Triggering events that accelerate a financial obligation (Item 2.04)
  • Departure or appointment of directors or officers (Item 5.02)
View Current report (8-K) filed 30 Sep 2026 on sec.gov (opens in a new tab)Filing index for 0001104659-26-112399 (opens in a new tab)
10-QEvent 30 Jun 2026 Quarterly report (10-Q) View Quarterly report (10-Q) filed 13 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001104659-26-095979 (opens in a new tab)
8-K Current report (8-K)
  • Departure or appointment of directors or officers (Item 5.02)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 18 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001104659-26-075849 (opens in a new tab)
4Event 5 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 8 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001104659-26-071436 (opens in a new tab)
4 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 5 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001104659-26-071048 (opens in a new tab)
4 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 5 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001104659-26-071039 (opens in a new tab)
4 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 5 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001104659-26-071038 (opens in a new tab)
8-K Current report (8-K)
  • Departure or appointment of directors or officers (Item 5.02)
View Current report (8-K) filed 5 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001104659-26-071027 (opens in a new tab)
10-QEvent 31 Mar 2026 Quarterly report (10-Q) View Quarterly report (10-Q) filed 13 May 2026 on sec.gov (opens in a new tab)Filing index for 0001104659-26-060359 (opens in a new tab)
10-KEvent 31 Dec 2025 Annual report (10-K) View Annual report (10-K) filed 15 Apr 2026 on sec.gov (opens in a new tab)Filing index for 0001104659-26-043822 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Insider transactions

All rows for Petros Pharmaceuticals, Inc. on Insider Trades

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P
None in this period
Sells code S
None in this period
Other all other codes
None in this period

Last transaction:

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Nothing on this page is investment advice.